Ozata M, Ozkardes A, Dolu H, Corakçi A, Yardim M, Gundogan M A
Department of Endocrinology and Metabolism, Gulhane School of Medicine, Etlik-Ankara, Turkey.
J Endocrinol Invest. 1996 Nov;19(10):670-7. doi: 10.1007/BF03349037.
Deficiency or excess of thyroid hormones is associated with central nervous system (CNS) disturbances. Although the CNS involvement either in hypothyroidism or in hyperthyroidism have previously been shown on the basis of visual, auditory and somatosensory evoked potentials studies, less is known about the function of central motor pathways in both disorders. We studied the motor evoked potentials (MEPs) following the magnetic stimulation of the motor cortex and spinal roots in 20 patients with hypothyroidism and in 19 patients with hyperthyroidism both before treatment and after they became euthyroid and compared with findings in 20 age-, sex- and height-matched control subjects. Disease duration (expressed as time from diagnosis of diseases to the time of neurological testing) is less than one month in both disorders. Central motor conduction time (CMCT) was determined as the differences between MEPs latencies after cortical and spinal stimulation. The mean CMCTs before treatment in hypothyroid patients (8.31 +/- 1.52 msec.) and in hyperthyroid patients (7.92 +/- 1.06 msec.) were significantly prolonged as compared to those in normal controls (6.82 +/- 0.83 msec. p = 0.002 and p = 0.004, respectively). Four of the 20 (20.0%) hypothyroid patients and 2 of 19 (10.5%) hyperthyroid patients had abnormal CMCT (values exceeding mean +2.5 SD of normal control). The mean CMCT values in both groups were not significantly decreased after euthyroidism was achieved, although a tendency of the decrease in CMCT was observed. Improvement of CMCT abnormalities was observed in 1 of 4 hypothyroid patients and in one of 2 patients with hyperthyroidism, who had CMCT abnormalities before treatments, after they became euthyroid. No correlation was found between CMCT and free T3, free T4, or TSH levels as well as the onset age, the severity of the diseases or the disease duration in both disorders. We conclude that abnormal CMCT could be documented in few patients in both disorders. However, these alterations could not be improved completely after restoration of euthyrodism. Thus, it remains to be determined if long-term treatment would completely improve CMCT abnormalities in both disorders. Since abnormal CMCT values in both disorders were observed only in few patients, our results also suggest that CMCT measurement does not have, at present time, a clinical usefulness to assess the peripheral action of thyroid hormones. Thus, the data obtained need a more extensive evaluation.
甲状腺激素的缺乏或过量与中枢神经系统(CNS)紊乱有关。尽管先前基于视觉、听觉和体感诱发电位研究已表明中枢神经系统在甲状腺功能减退症或甲状腺功能亢进症中均有受累,但对于这两种疾病中中枢运动通路的功能了解较少。我们研究了20例甲状腺功能减退症患者和19例甲状腺功能亢进症患者在治疗前及甲状腺功能恢复正常后,经磁刺激运动皮层和脊髓神经根后的运动诱发电位(MEP),并与20例年龄、性别和身高匹配的对照受试者的结果进行比较。两种疾病的病程(从疾病诊断到神经学检查的时间)均小于1个月。中枢运动传导时间(CMCT)被确定为皮层和脊髓刺激后MEP潜伏期的差异。与正常对照组(6.82±0.83毫秒,p = 0.002和p = 0.004)相比,甲状腺功能减退症患者(8.31±1.52毫秒)和甲状腺功能亢进症患者(7.92±1.06毫秒)治疗前的平均CMCT显著延长。20例甲状腺功能减退症患者中有4例(20.0%)和19例甲状腺功能亢进症患者中有2例(10.5%)的CMCT异常(值超过正常对照组平均值+2.5标准差)。尽管观察到CMCT有下降趋势,但两组患者甲状腺功能恢复正常后,平均CMCT值并未显著降低。在治疗前CMCT异常的4例甲状腺功能减退症患者中的1例和2例甲状腺功能亢进症患者中的1例,在甲状腺功能恢复正常后,观察到CMCT异常有所改善。在这两种疾病中,未发现CMCT与游离T3、游离T4或TSH水平以及发病年龄、疾病严重程度或病程之间存在相关性。我们得出结论,在这两种疾病中,少数患者可记录到CMCT异常。然而,甲状腺功能恢复正常后,这些改变并不能完全改善。因此,长期治疗是否能完全改善这两种疾病中的CMCT异常仍有待确定。由于仅在少数患者中观察到这两种疾病的CMCT值异常,我们的结果还表明,目前CMCT测量对评估甲状腺激素的外周作用没有临床实用性。因此,所获得的数据需要更广泛的评估。